Ovintiv CEO Brendan McCracken Exercises SARs, Sells 5,098 Shares

What Happened

• Brendan McCracken, President & CEO and a director of Ovintiv Inc. (OVV), exercised 5,098 stock appreciation rights (SARs) and then disposed of the resulting 5,098 shares to the issuer. The exercise reported an aggregate intrinsic cost of $116,999 (5,098 shares × $22.95 exercise price) and the subsequent disposition to the issuer was at $63.56 per share for proceeds of $324,029. The filing also shows a derivative line with a $0.00 amount related to the SAR settlement.

Key Details

• Transaction date: 2026-08-11; Form filed: 2026-08-13 (appears timely)
• Exercise (code M): 5,098 SARs exercised at $22.95; aggregate reported $116,999
• Disposition to issuer (code D): 5,098 shares disposed at $63.56; proceeds $324,029
• Additional derivative line (code M) shows 5,098 with $0.00—related to SAR settlement
• Shares owned after the transactions: not specified in the provided filing excerpt
• Footnote: F1 — Each Stock Appreciation Right is the economic equivalent of one share of Ovintiv common stock

Context

• SARs function like options tied to share price appreciation. Here the exercised SARs were immediately disposed to the issuer, consistent with a cashless exercise/settlement or share-withholding to satisfy obligations. Such insider sales can be routine (e.g., tax withholding or planned exercises) and are not, by themselves, a reliable signal of company outlook.